Article 2 Amendment of Schedule 1 to the principal Order

(1)

Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of that Order) is amended in accordance with the following provisions of this article.

(2)

In Table A (internal or external use)—

(a)

there are inserted in column 1 and, as the case may be, columns 2, 3 and 4, the entries set out in columns 1, 2, 3 and 4 respectively of Schedule 1 to this Order;

(b)

in relation to the substance “Benzoin Tincture, Compound BP”—

(i)

there is inserted in column 2 the entry

“(2)

0.8 per cent.”, and

(ii)

there are substituted, for the entries in column 3, the entries

“(1)

Internal: vapour inhalations

(2)

Internal: pastilles

(3)

External”;

(c)

in relation to the substance “Folic Acid”, there is substituted for the entry in column 4 the entry “500 mcg (MDD)”.

(3)

In Table B (external use only), there are inserted in column 1 and, as the case may be, columns 2 and 3, the entries set out in columns 1, 2 and 3 respectively of Schedule 2 to this Order.